Alexion to Acquire Wilson Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Alexion Pharmaceuticals (ALXN) PT Raised to $113 at Jefferies on Plan to Acqurie WTX101
April 11, 2018 11:37 AM EDTJefferies raised its price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $113.00 (from $112.00) while maintaining a Hold rating.
Analyst Eun Yang said the clinical risk is low, but the commercial risk seems tougher.
... More